Market | Children's Drug Market Analysis and Policy Inventory: China Chapter

As we mentioned earlier, the United States is currently the world’s largest market for children’s medicines; China is closely followed and is the world’s second largest market for children’s medicines.

However, compared with the United States, which has formal child medication legislation and mature child medication policies and regulations, the development of domestic child medication shows many shortcomings:

the first

Domestic drug manufacturers lack enthusiasm.

second

There are not enough domestic children's medicine production enterprises, and the varieties and suitable dosage forms produced are also relatively lack; and the varieties produced are of high homogeneity, and the advantages of the products are insufficient.

The children's drug market in my country is dominated by respiratory system drugs, digestive system drugs, anti-infective drugs, and nutritional supplements.

third

There is no systematic legal and regulatory system for children’s medicines and a complete list of essential medicines for children; in addition, the 2017 version of the medical insurance catalogue (2,535 Western medicines and proprietary Chinese medicines) has clearly defined 540 medicines or dosage forms suitable for children.

In my country, the concept of children usually refers to minors aged 0-14.

On December 1, 2019, the new version of the "Drug Administration Law" was officially implemented.

In addition, in recent years, the National Medical Products Administration (NMPA) has successively issued some revision announcements of drug inserts, adding relevant content about children's medication.

Summary and discussion

I don't know the true face of Mount Lu, but I am in this mountain.

*Note: This article does not constitute any value judgment or investment advice.

Reference materials:

1-2019 China's children's drug industry market analysis

2-NMPA official website information

3-CDE official website information